Trials / Conditions / Advanced Squamous Non Small Cell Lung Cancer
Advanced Squamous Non Small Cell Lung Cancer
6 registered clinical trials studyying Advanced Squamous Non Small Cell Lung Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cyt NCT07418931 | Gruppo Oncologico Italiano di Ricerca Clinica | Phase 2 |
| Active Not Recruiting | AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer NCT05840016 | Akeso | Phase 3 |
| Unknown | Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung NCT05900921 | Sichuan University | Phase 2 |
| Active Not Recruiting | Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC NCT04497584 | University of Texas Southwestern Medical Center | Phase 2 |
| Unknown | Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer NCT03808701 | Sinocelltech Ltd. | Phase 1 |
| Terminated | QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment NCT00807612 | NantCell, Inc. | Phase 1 / Phase 2 |